Drug intelligence / Profile preview

2-ethylhexyl 4-phenylbenzophenone-2'-carboxylate

Development stage: Unknown
Lead developer: Merck KGaA
Modality: Small Molecules
Administration: Topical

Overview

2-Ethylhexyl 4-phenylbenzophenone-2'-carboxylate is a synthetic small molecule compound primarily used as an ingredient in sunscreens. It functions as a UV-A absorber, helping to protect the skin from ultraviolet A radiation by absorbing and dissipating harmful rays. The compound is also known under the code name Eusolex 3573 and has been classified as experimental in drug databases. Its main application is topical, for photoprotection rather than treatment of disease[1][4].

Other names: 2-ethylhexyl 2-(4-phenylbenzoyl)benzoate

Beyond the preview

Go deeper on 2-ethylhexyl 4-phenylbenzophenone-2'-carboxylate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2-ethylhexyl 4-phenylbenzophenone-2'-carboxylate.

Explore the full profile